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Abstract 19 
Oxidative stress is one of the most critical factors implicated in many disorders of the 20 
gastrointestinal tract, such as inflammatory bowel diseases and colon cancer. Lunasin is a 21 
seed peptide known by its properties against cancer and cardiovascular diseases. The present 22 
study investigated the in vitro antioxidant activity of this peptide that demonstrated to be a 23 
potent scavenger of peroxyl and superoxide radicals. In addition, the protective role of lunasin 24 
on cell viability and antioxidant defenses of human Caco-2 cells challenged by hydrogen 25 
peroxide and tert-butylhydroperoxide was evaluated. This peptide remained partially intact 26 
during incubation time with cells, preventing of the oxidative damage induced by both 27 
chemical agents. The direct antioxidant action of lunasin (within the physiological range of 28 
concentrations) on enterocytes exposed to oxidizing species makes this peptide a promising 29 
agent to preserve the integrity of intestinal mucosa against oxidative damage related diseases. 30 
 31 
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1. Introduction 33 
During cell metabolism, oxygen is partially reduced to reactive oxygen species (ROS). 34 
These species play a physiological role in cellular processes, including proliferation, cell 35 
cycle and death, and signal transduction (Martindale and Holbrook, 2002; Owuor and Kong, 36 
2002). However, their high reactivity makes ROS being responsible for oxidation of lipid, 37 
proteins and DNA causing damaging effects on vital tissues. Mammalian cells express 38 
detoxifying or radical scavenging systems that counteract the destructive effects of ROS. 39 
Nevertheless, high levels of these species caused by an imbalance between their production 40 
and the ability of the antioxidant defences to detoxify the organism provoke a status of 41 
oxidative stress. This status and its subsequent damages to vital cellular components have 42 
been associated with numerous severe degenerative diseases (Carocho and Ferreira, 2013). 43 
The intestine is continuously exposed to reactive species endogenously generated from 44 
luminal contents as well as to oxidants daily ingested with the foods (Couto et al., 2012). A 45 
large literature exists on the pivotal role that ROS play in the physiology and pathology of the 46 
intestine as well as in the microbiota profile (Pavlick et al., 2002; Graham Espey, 2013). 47 
Moreover, many disorders of the gastrointestinal tract, such as inflammatory bowel diseases 48 
and colon cancer are associated with increased levels of ROS and alterations in the redox 49 
status of intestinal cells (Udilova et al., 2003; Wijeratne and Cuppett, 2007; Rezaie et al., 50 
2007). 51 
In spite of its remarkable effectiveness, the endogenous antioxidant systems are not 52 
sufficient, and humans, in order to maintain ROS concentrations at low levels, are dependent 53 
on antioxidants present in the diet (Pietta, 2000). A number of natural dietary antioxidants 54 
have been revealed as potential preventative/therapeutic agents against oxidative stress 55 
(Carocho and Ferreira, 2013). Among them, food-derived peptides have attracted the attention 56 
because of the large evidence on their in vitro antioxidant properties (Power et al., 2013). In 57 
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addition to their potential as safer alternatives to synthetic antioxidants used to prevent 58 
oxidative reactions in foods, antioxidant peptides can also act reducing the risk of numerous 59 
oxidative stress-associated diseases (Meisel, 2004). Furthermore, peptides can act 60 
synergistically with non-peptide antioxidant enhancing their protective effect (Kitts and 61 
Weiler, 2003; Hernández-Ledesma et al., 2007). 62 
Lunasin is a 43-amino acid peptide identified in soybean and other plants (Gálvez and 63 
de Lumen, 1999). It has been demonstrated to be present in all the soybean varieties analyzed 64 
to date, at concentrations ranged from 4.4 to 70.5 mg lunasin/g of soy protein (Hernández-65 
Ledesma et al., 2009a). Daily consumption of 25 g of soy protein, recommended by Food and 66 
Drug Administration (FDA) to reduce coronary disease (FDA, 1999), supplies lunasin in 67 
quantity ranged from 110 mg (21 mol) to 1760 mg (350 mol). It is known that lunasin is 68 
protected by the soybean Bowman-Birk proteases inhibitor (BBI) against the action of gastric 69 
and pancreatic enzymes (Hernández-Ledesma et al., 2009b). Therefore, high percentage of 70 
daily ingested peptide remains intact during its passage through the gastrointestinal tract, 71 
reaching target organs and tissues in an intact and active form (Hsieh et al., 2010). It has been 72 
demonstrated, by both cell culture and animal models, that this peptide exerts potent 73 
chemopreventive properties against several types of cancer, such as breast, colon, and prostate 74 
cancer, acting through different cellular and molecular pathways (see review of Hernández-75 
Ledesma et al., 2013). Moreover, this peptide is already commercialized in the US by its 76 
reported effects on cardiovascular system as reducing agent of low density lipoprotein (LDL) 77 
cholesterol concentration (Gálvez, 2012). Preliminary studies have suggested that lunasin 78 
exerts antioxidant and anti-inflammatory properties that might contribute on its physiological 79 
properties (Hernández-Ledesma et al., 2009c; Cam et al., 2013). However, to date, no 80 
information about the direct protective effects of this peptide against cellular oxidative stress 81 
status have been reported.   82 
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Because of the directly interaction between food and intestine, nowadays, it exists a 83 
great interest to evaluate the capacity of food antioxidants to protect intestinal epithelium 84 
against oxidative stress conditions, and subsequently against the development of intestinal 85 
pathologies. The present paper aimed to assess the in vitro antioxidant activity of peptide 86 
lunasin through radical scavenging and ferrous ion chelating activities. Also, the protective 87 
effects of this peptide against the oxidative damage to intestinal mucosa were evaluated, using 88 
differentiated human Caco-2 cells as a model of the human intestine, and two chemical 89 
agents, hydrogen peroxide (H2O2) and tert-butyl hydroperoxide (t-BOOH) as inducing agents.  90 
 91 
2. Materials and Methods 92 
2.1. Reagents 93 
Peptide lunasin was synthesized by Chengdu KaiJie Biopharm Co., Ltd (Chengdu, 94 
Sichuan, P. R. China). Fluorescein disodium (FL), phenazine methosulfate (PMS), nitroblue 95 
tetrazolium chloride (NBT), -nicotinamide adenine dinucleotide (NADH), superoxide 96 
dismutase (SOD), ethylenediaminetetraacetic acid (EDTA), ferrozine, trifluoroacetic acid 97 
(TFA), 3-[4,5-dimethylthiazol-2-yl]-2,3-diphenyl tetrazolium bromide (MTT), 98 
dichlorofluorescin (DCFH), and dihydrorhodamine (DHR) were purchased from Sigma 99 
Chemical (St. Louis, MO, USA). 2,2’-azobis (2-methylpropionamide)-dihydrochloride 100 
(AAPH), and 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) were from 101 
Aldrich (Milwaukee, WI, USA).  The rest of chemicals used were of HPLC grade. 102 
 103 
2.2. In vitro antioxidant activity 104 
2.2.1. Oxygen radical absorbance capacity assay 105 
An oxygen radical absorbance capacity (ORAC)-FL assay was used based on that 106 
optimized for protein hydrolyzates and peptides by Hernández-Ledesma et al. (2005). Briefly, 107 
the reaction was carried out at 40 ºC in 75 mM phosphate buffer (pH 7.4). The final assay 108 
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mixture (200 L) contained FL (70 nM), AAPH (14 mM) and antioxidant [Trolox (0.2-1.6 109 
nmol) or sample (at different concentrations)]. Fluorescence was recorded during 137 min 110 
(104 cycles) in a FLUOstar OPTIMA plate reader (BMG Labtech, Offenburg, Germany) with 111 
485 nm excitation and 520 nm emission filters. The equipment was controlled by the 112 
FLUOstar Control ver. 1.32 R2 software for fluorescence measurement. Three independent 113 
runs were performed for each sample. Final ORAC-FL value was expressed as mol Trolox 114 
equivalent/ M peptide. 115 
 116 
2.2.2. Superoxide anion scavenging activity 117 
Measurement of superoxide anion scavenging activity of lunasin was investigated 118 
according to the method reported by Li et al. (2011) and optimized in our laboratory for its 119 
use in microplates. The reaction was carried in 0.1 M phosphate buffer (pH 7.4) with a final 120 
mixture volume of 200 L that contained PMS (60 M, 50 L), NBT (156 M, 50 L), 121 
NADH (468 M, 50 L), and antioxidant [SOD (0.078-40 M) or lunasin (0.15-20 M)]. 96-122 
well microplates (Nunc maxisorp F96, Roskilde, Denmark) were used. The reaction mixture 123 
was incubated at 25 °C for 5 min, and the absorbance at 560 nm was measured on a 124 
Varioskan Flash microplate reader (Thermo Fisher Scientific, Waltham, MA, USA).  125 
The capability of scavenging to superoxide radical was calculated using the following 126 
equation: 127 
Scavenging capacity (%) = (A1 − A2) × 100/(A3 – A2) 128 
where A1 is the absorbance of the sample, A2 is the absorbance of the blank and A3 is the 129 
absorbance of the control. 130 
Three independent runs were performed for each sample. The SOD or lunasin 131 
concentration ( M) needed to scavenge 50% of superoxide anion radicals (IC50 value) was 132 
determined using the software GraphPadPrism v.4.01 (GraphPad, La Jolla, CA, USA). 133 
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2.2.3. Ferrous ion chelating activity 134 
The ferrous ion chelating activity assay was performed according to Decker and 135 
Welch (1990) with some modifications, and using EDTA as standard. The reaction mixture 136 
containing 1 mL of 100 mM sodium acetate buffer (pH 4.9), 100 L of 181.4 M 137 
FeCl2.4H2O, and 100 L of antioxidant  [EDTA or lunasin (1.25-80 M)] was incubated at 25 138 
°C for 5 min. After this time, 50 L of ferrozine solution (40 mM) were added and the 139 
mixture was gently shaken. A volume of 200 L of the mixture was placed in 96-well 140 
microplates (Nunc maxisorp F96) and the absorbance was read at 562 nm on the Varioskan 141 
Flash microplate reader (Thermo Fisher Scientific). 142 
The capability of metal chelating was calculated using the following equation: 143 
Chelating capacity (%) = (A1 − A2) × 100/A3 144 
where A1 is the absorbance of the sample, A2 is the absorbance of the blank and A3 is the 145 
absorbance of the control. 146 
Three independent runs were performed for each sample. The concentration ( M) of 147 
EDTA or lunasin needed to reduce 50% ferrous ions (IC50 value) was determined using the 148 
software GraphPadPrism v.4.01 (GraphPad). 149 
 150 
2.3. Cell culture  151 
Caco-2 cells were obtained from the American Type Culture Collection (HTB-38, 152 
Rockville, MD, USA), and were used between passages 30 and 40. The cells were maintained 153 
in 75 cm
2
 flaks in Dulbecco's Modified Eagle Medium (DMEM, Sigma Chemical) with 10% 154 
(v/v) fetal bovine serum (FBS, Sigma Chemical), 1% (v/v) nonessential amino acids (Lonza 155 
Group Ltd., Basel, Switzerland), and 1% (v/v) antibiotic solution with fungizone (Lonza 156 
Group Ltd.) at pH 7.2-7.4. The cells were maintained at 37ºC in an incubator under a 5% 157 
CO2/95% air at constant humidity. Culture medium was changed every 2 days.  158 
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The cells at 70% confluence were detached with trypsin-EDTA (2.5 g/L trypsin, 0.2 159 
g/L EDTA), harvested from the flask, and suspended in culture medium. They were seeded 160 
onto polyester membrane chamber inserts (12 mm diameter, 0.4 m pore size; Transwell
®
, 161 
Corning Costar Corp., Corning, NY, USA) at a density of 5 × 10
4
 cells/cm
2
, with 1 mL of 162 
medium in the basolateral chamber and 0.75 mL of suspended cells in the apical chamber. 163 
Seven to nine days after the initial seeding, the integrity of the monolayer of differentiated 164 
cells was monitored by measuring the transepithelial electrical resistance (TEER) value. Cells 165 
with values higher than 400 Ω x cm2 were used in the assays.  166 
 167 
2.4. Stability of lunasin 168 
Caco-2 cells were seeded onto 6-well plates (Corning Costar Corp.) at a density of 5 × 169 
10
4
 cells/cm
2
. The culture medium was changed every two days, and at seven to nine days 170 
from initial seeding, the culture medium was aspirated, and cell monolayers were washed 171 
with phosphate buffer saline (PBS). Then, cell cultures were treated with 2.5 M lunasin and 172 
incubated at 37ºC for 24 h, taking supernatant samples at 0, 6, 16, and 24 h of incubation.  173 
To analyze the relative amount of lunasin remaining in the culture medium after 174 
treatment with this peptide, the supernatants were subjected to RP-HPLC coupled to tandem 175 
mass spectrometry (RP-HPLC-MS/MS) analysis on an Agilent 1100 HPLC System (Agilent 176 
Technologies, Waldbron, Germany) connected on-line to an Esquire 3000 ion trap (Bruker 177 
Daltonik GmbH, Bremen, Germany) and equipped with an electrospray ionization source as 178 
previously described (Silveira et al., 2013). The column used was a Mediterranea Sea18 (150 x 179 
2.1 mm, Teknokroma, Barcelona, Spain), the injection volume was 50 µL, and the flow was 180 
set at 0.2 mL/min. Peptides were eluted with a linear gradient of solvent B 181 
(ACN:trifluoroacetic acid (TFA) 1000:0.27 v/v) in A (water:TFA 1000:0.37 v/v) going from 182 
0% to 45% in 130 min. The m/z spectral data were processed and transformed to representing 183 
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mass values, and the peak area corresponding to lunasin and/or its derived fragments were 184 
integrated Using Data Analysis™ (version 4.0; Bruker Daltonics). 185 
 186 
2.5. Cell treatment conditions 187 
 Cells were incubated for 24 h with various concentrations of peptide lunasin, ranged 188 
from 0.5 to 25 M. To evaluate both direct and protective effects against oxidative stress, the 189 
incubation period was followed by a 3 h treatment with culture medium (direct effect) or 190 
oxidant chemicals H2O2 (4 mM) or t-BOOH (3 mM). In both cases, different biomarkers were 191 
evaluated.  192 
 193 
2.5.1. Cell viability  194 
Cell viability was determined using the MTT assay. It is based on the reduction of the 195 
tetrazolium ring of MTT by mitochondrial dehydrogenases, yielding a blue formazan product, 196 
which can be measured spectrophotometrically. Caco-2 cells were seeded onto 48-well plates 197 
(VWR International, Radnor, PA, USA) at a density of 5 × 10
4
 cells/cm
2
. After seven to nine 198 
days from initial seeding, cell monolayers were washed with PBS, treated with lunasin, and 199 
incubated overnight. Afterwards, culture medium was removed, cells were washed with PBS 200 
and incubated with medium or chemical oxidants at 37 ºC for 1.5 and 3 h. MTT solution (0.5 201 
mg/mL final concentration) was added to each well, and the cells were incubated for 2 h at 37 202 
ºC. The supernatant was aspirated and insoluble formazan crystals formed were dissolved in 203 
dimetilsulfoxide:ethanol (1:1), measuring the absorbance at 570 nm in a FLUOstar OPTIMA 204 
plate reader (BMG Labtech). 205 
The results were expressed as percentage of the control, considered as 100%. 206 
Experiments were carried out in triplicate, and the results were expressed as the mean ± 207 
standard deviation (SD). 208 
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2.5.2. Intracellular ROS levels 209 
2.5.2.1. Measurement of ROS by fluorescence 210 
Intracellular ROS levels were quantified following the method described by Alía et al. 211 
(2005), using DCFH as fluorescent probe. Caco-2 cells were treated with lunasin as 212 
mentioned above. After 23.5 h incubation with the peptide, a solution of DCFH solution was 213 
added to each well (5 M final concentration) and cells were incubated for 30 min at 37 ºC. 214 
Then, the cells were incubated with culture medium (direct effects) or subjected to chemical-215 
induced oxidative stress with H2O2 or t-BOOH (protective effects) for 1.5 or 3 h. Afterwards, 216 
the fluorescence intensity was measured at excitation and emission of 485 nm and 530 nm, 217 
respectively, in a FLUOstar OPTIMA plate reader (BMG Labtech). The results were 218 
expressed as percentage of the control, considered as 100%. The assay was run in triplicate, 219 
and the results were expressed as the mean ± SD.  220 
 221 
2.5.2.2. Measurement of ROS by flow cytometry 222 
The intracellular accumulation of ROS in Caco-2 cells under chemical inducing 223 
conditions was also evaluated by flow cytometry using DHR, which is oxidized to fluorescent 224 
rhodamine (Cilla et al., 2008). Caco-2 cells were treated with lunasin as above mentioned. 225 
Then, the culture medium was removed, cell monolayers were washed with PBS, and 226 
resuspended in a trypsin-EDTA solution. After centrifuging the cells at 1200 rpm for 5 min, 227 
they were dissolved in 0.5 mL of DHR (final concentration 5 µM), and incubated for 30 min 228 
at 37 ºC in darkness. Fluorescent intensity was determined by flow cytometry at excitation and 229 
emission of 488 nm 525 nm, respectively in a FACSCalibur flow cytometer (Becton Dickinson, 230 
Franklin Lakes, NJ, USA). The results were analyzed using the software Kaluza Flow 231 
Cytometry Analysis Version 1.2 (Beckman Coulter Inc., Brea, CA, USA). The data were 232 
obtained from the six replicates, and the results were expressed as the mean ± standard 233 
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deviation (SD). Control cells were used throughout each assay. At least 5,000 cells per sample 234 
were analyzed. 235 
 236 
2.8. Statistical analysis  237 
Data were analyzed by a one-way ANOVA, followed by the Tukey’s test. Statgraphics 238 
Plus v.5.1 software (Rockville, MD, USA) was used to find significant differences (p<0.05) 239 
 240 
3. Results and Discussion 241 
3.1. In vitro antioxidant capacity of lunasin 242 
 The antioxidant capacity of lunasin was assessed through its ability to scavenge 243 
peroxyl and superoxide radicals, as well as its ferrous ion chelating activity. Figure 1a and 1b 244 
shows the concentration ( mol in the assay) ranges that ensured linearity between the net area 245 
under the curve (Net AUC) and the concentration of antioxidant (Trolox or lunasin). To 246 
determine the ORAC value of lunasin, the slope of the net AUC versus concentration curve 247 
was divided by the slope of the Trolox calibration curve. The ORAC value for lunasin was of 248 
3.44 ± 0.07 mol Trolox equivalents/ mol lunasin. This activity was higher than that of 249 
natural antioxidants such as vitamin C (1.65 mol Trolox equivalents/ mol vitamin C) 250 
(Huang et al., 2010), or synthetic antioxidants such as butylated hydroxyanisole (BHA) (2.43 251 
mol Trolox equivalents/ mol BHA) (Dávalos et al., 2004). As shown in the ORAC database 252 
prepared by Li and Li (2013), length of peptides derived from food sources with peroxyl 253 
radical scavenging activity was from 4 to 20 amino acids. To our knowledge, lunasin, with 43 254 
amino acids, is the first peptide containing more than 20 amino acids that shows this activity. 255 
Potent activity of lunasin was attributed to the presence of amino acids Trp, Cys, and Met in 256 
its sequence (Hernández-Ledesma et al., 2005). These amino acids were also suggested to be 257 
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responsible for the ABTS radical scavenging activity reported for this peptide (Hernández-258 
Ledesma et al., 2009c).  259 
 In the present study, it was also demonstrated the capacity of lunasin to neutralize 260 
superoxide radicals. The effect was dose-dependent at concentrations ranged from 0.15 to 5 261 
M, reaching 61.6% neutralization at 5 M, and maintaining a constant neutralization value 262 
at higher concentrations (data not shown). The effect was compared to that of enzyme SOD 263 
that reached 75.0% neutralization at 10 M. In the linear range, the IC50 or concentration of 264 
antioxidant needed to neutralize 50% radicals was calculated, and values of 0.85 M and 2.34 265 
M were obtained for lunasin and SOD, respectively. The ability of lunasin to chelate ferrous 266 
ions was also evaluated. At the maximum concentration used in the assay (80 M), lunasin 267 
only chelated 23.9% of these ions, while EDTA used as standard was able to chelate 100% 268 
ions at 10 M. However, the study carried out by Jeong et al. (2010) showed that lunasin 269 
purified from Solanum nigrum L. chelated ferrous ions by 73% at 10 M. Discrepancy with 270 
our results could be due to the different origin of lunasin. In our study, synthetic lunasin 271 
according to the sequence identified in soybean demonstrated potent antioxidant properties 272 
through scavenging of free radicals.  273 
 274 
3.2. Stability of lunasin 275 
In order to evaluate the protective effects of lunasin against oxidative stress, it was 276 
initially needed to study the behavior of this peptide after its addition to Caco-2 cells. It has 277 
been demonstrated that these cells undergo a process of differentiation leading to the 278 
formation of a monolayer of cells, expressing multiple morphological and functional 279 
characteristics of the mature enterocyte (Sambuy et al., 2005). The first objective was to 280 
assess the resistance of this peptide to brush-border membrane peptidases expressed in Caco-2 281 
cells after its addition to DMEM. For that, the medium without and with lunasin (2.5 M) at 282 
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different incubation hours (0, 6, 16, and 24 h) was analyzed by HPLC-MS/MS. It was 283 
observed that, in addition to other components present in the medium, lunasin was clearly 284 
visible along the incubation time. As an example, Figure 2a shows the chromatogram 285 
obtained after 16 h-incubation of cells without and with lunasin. The lunasin’s peak area was 286 
measured (Figure 2b), and a decrease in content of this peptide with the incubation time was 287 
observed, reaching 12% reduction of this peptide after 16 h compared to the content measured 288 
at the starting incubation point. The rest of lunasin (88%) remained intact in the medium and 289 
no derived fragments were identified. These results suggest the possibility of lunasin’s 290 
internalization into human intestinal Caco-2 cells. If this fact is confirmed, lunasin might 291 
exert a potential protective role inside and outside the cell. Preliminary studies carried out 292 
with mouse C3H10T1/2 and NIH3T3 fibroblast cells demonstrated that lunasin was 293 
internalized by these cells (Galvez et al., 2001). Moreover, a recent study has reported the 294 
internalization of lunasin into human macrophages that is amplified when these cells are in an 295 
inflammatory state (Cam et al., 2013).  296 
 297 
3.3. Cell viability  298 
The direct effects of lunasin on Caco-2 cells viability were evaluated using the MTT 299 
assay. This assay provides a sensitive measurement of the cell metabolic status, specifically of 300 
the mitochondria, which displays early cellular redox changes (Circu and Aw, 2010). 301 
Treatment of Caco-2 cells for 24 h with lunasin evoked no changes in cell viability, indicating 302 
that the concentrations selected for the study (0.5-25 M) did not damage cell integrity during 303 
the period of incubation. As mentioned above, Caco-2 cell line, originally derived from 304 
human colon carcinoma, can spontaneously differentiate into intestinal epithelium under 305 
standard culture conditions and the differentiated cells express enterocyte-like features. These 306 
results are in agreement with previous studies that indicated that lunasin does not affect 307 
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viability of non-transformed cells while viability of transformed cells by chemical agents or 308 
oncogenes, and tumorigenic cells is notably affected by this peptide (Lam et al., 2003; Galvez 309 
et al., 2011).  310 
To study the protective effects of lunasin against chemical-induced oxidative damage 311 
in Caco-2 cell monolayers, they were pre-incubated with lunasin for 24 h, exposed to H2O2 or 312 
t-BOOH for 1.5 and 3 h, and then, cell viability was measured by the MTT assay. As shown 313 
in Figure 3a, treatment of Caco-2 cells with H2O2 (4 mM) for 1.5 h provoked a significant 314 
reduction of cell viability of 30%, compared to non-stimulated cells. Longer treatment (3 h) 315 
with this chemical did not result in a higher reduction of cell viability (data not shown). 316 
Previous studies had also reported significant decreases of cell viability after treatment of 317 
Caco-2 cells with 5 mM H2O2 for 2 h (Laparra et al., 2008; García-Nebot et al., 2011) or 318 
concentrations of this chemical in the range from 0.3 to 10 mM for 20 h (Yokomizo and 319 
Moriwaki, 2006). In the case of t-BOOH (3 mM), treatment for 1.5 h resulted in 20% 320 
reduction of Caco-2 cells viability (Figure 3b). However, previous studies had observed 321 
significant reductions at longer incubation time (6 h) using concentrations of this chemical of 322 
0.1 mM and 4 mM (Manna et al., 2005; Kim et al., 2013). 323 
Pretreatment of Caco-2 cells with lunasin before induction with H2O2 for 1.5 h 324 
protected cells from the effects of this chemical. As shown in Figure 3a, the percentage of 325 
viable cells treated with lunasin at concentrations of 1-25 M before addition of H2O2 was 326 
significantly higher to that observed for non-treated cells, being similar to that observed for 327 
non-stressed cells. However, for Caco-2 cells stimulated with t-BOOH, only the pretreatment 328 
with 1 M lunasin resulted in a significant increase of viable cells up to levels of non-stressed 329 
cells (Figure 3b). Higher lunasin’s concentrations also increased the percentage of viable cells 330 
but the final values were not significantly different from those obtained for stressed-cells. 331 
Moreover, lunasin did not protect cells from the effects of t-BOOH when this chemical was 332 
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incubated for 3 h (data not shown). A higher damaging effect on viability was observed when 333 
Caco-2 cells were challenged with H2O2 than with t-BOOH, being lunasin able to exert more 334 
protective actions. In the last years, milk protein-derived hydrolyzates have demonstrated to 335 
preserve viability and protect against oxidative damage in different cell lines stimulated with 336 
H2O2. In particular, caseinophosphopeptides have demonstrated to exert this effect in H2O2-337 
induced Caco-2 cells (García-Nebot et al., 2011) while casein and whey protein hydrolyzates 338 
do it in H2O2-induced hepatic HepG2 and neuronal PC12 cells, respectively (Xie et al., 2013; 339 
Zhang et al., 2012). 340 
 341 
3.4. Intracellular ROS levels 342 
At gastrointestinal level, increased levels of ROS have been directly associated to 343 
inflammatory bowel diseases and colon cancer (Udilova et al., 2003; Wijeratne and Cuppett, 344 
2007; Rezaie et al., 2007). Direct evaluation of intracellular ROS is a good indicator of the 345 
oxidative damage to living cells (Wang and Joseph, 1999). In our study, measurement of the 346 
intracellular ROS levels was carried out using two fluorescent probes, DCFH and DHR. 347 
When applied to intact cells, the nonionic, nonpolar DCFH crosses cell membranes and in the 348 
presence of ROS, it is oxidized to highly fluorescent dichlorofluorescein (DCF) (LeBel et al., 349 
1992). This probe has better use as a marker of the overall oxidative stress in cells than as 350 
indicator of the formation of H2O2 or other ROS. As shown in Figure 4a, lunasin did not 351 
increase ROS production in non-stressed Caco-2 cells. However, we found that 4 mM H2O2 or 352 
3 mM t-BOOH challenge for 1.5 h significantly increased ROS levels (untreated cells 100.0 ± 353 
1.2; treated cells with H2O2 348.3 ± 18.0; treated cells with t-BOOH 479.1 ± 35.4) (p<0.05). 354 
The lower effect observed on ROS levels resulting from H2O2 challenge could be due to the 355 
poor activity of this agent on DCFH oxidation in such short induction time. It has been 356 
previously reported that H2O2 alone does not oxidize DCFH, requiring its previous 357 
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transformation to other ROS with higher oxidant capacity (Royall and Ischiropoulos, 1993). 358 
Other possible explanation of the higher degree of oxidative damage provoked by t-BOOH 359 
might be the higher stability of this chemical in aqueous solution than that of H2O2, permitting 360 
t-BOOH a longer and more sustained effect on the cell (Alía et al., 2005). The pre-treatment 361 
with lunasin for 24 h significantly neutralized the ROS-generating ability of both chemicals 362 
by Caco-2 cells (Figure 4a). In the case of H2O2-stressed cells, the highest protection was 363 
observed at lunasin concentration of 0.5 M that reduced ROS levels by 32.9% compared to 364 
non-lunasin treated cells (p<0.05). At higher lunasin concentrations, no further reduction was 365 
observed. However, for t-BOOH stressed cells, dose-dependent effects of lunasin on ROS 366 
levels were determined, reaching 62.7% reduction at 25 M (p<0.05).  367 
The second probe was DHR, a non-fluorescent molecule that, by oxidation, yields 368 
rhodamine 123, a cationic and lipophilic fluorescent probe which levels were measured with 369 
flow cytometry. As shown in Figure 4b, both chemicals induced a notable increase of ROS 370 
levels (without H2O2 100.0 ± 11.8; with H2O2 131.2 ± 11.7; with t-BOOH 162.8 ± 10.6). 371 
These results confirm the higher capacity of t-BOOH to induce oxidative stress in Caco-2 372 
cells than that shown by H2O2. Pre-treatment with lunasin resulted in an important reduction 373 
of ROS levels. In Caco-2 cells stressed with both chemicals, the maximum effect was 374 
observed at lunasin concentration of 1 M, reaching 54.4% of reduction in H2O2-stressed 375 
cells and 27.1% in t-BOOH-stressed cells, compared to non-lunasin treated cells (Figure 4b). 376 
In contrast to the effects observed with DCFH, when using DHR, most potent effects were 377 
observed when Caco-2 cells were pre-incubated with lunasin before H2O2 challenge, in which 378 
ROS levels were decreased up to levels lower than those measured in non-challenged cells. 379 
The differences between both fluorescent probes could be due to the molecular basis of the 380 
determinations or to the singular specificity of each probe. Halliwell and Whiteman (2004) 381 
and Gomes et al. (2005) have demonstrated that DHR is a probe widely used to detect several 382 
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ROS, such as OH
•
, ONOO
−
, or NO2
−
, but is poorly responsive to O2
•−
, H2O2 or NO
•
. 383 
Moreover, the differences found with DCFH and DHR might reflect the different molecular 384 
basis of these determinations. 385 
The protective effects of lunasin on intestinal cells against oxidative damage reducing 386 
ROS production is in agreement with previous results of this study indicating that this peptide 387 
is an effective scavenger of superoxide and peroxyl radicals in vitro. To date, few peptides 388 
have demonstrated to exert protective effects against oxidative damage at intestinal level. 389 
Recently, García-Nebot et al., (2011) revealed this ability for caseinophosphopeptides 390 
obtained after digestion of casein under simulated gastrointestinal digestion.  391 
 392 
4. Conclusions 393 
In summary, our results have demonstrated that physiological doses of lunasin exert a 394 
protective effect in Caco-2 cells against H2O2 and t-BOOH-induced oxidative stress and 395 
subsequent cell death. This effect it mainly produced through its ability to scavenge ROS. Our 396 
results point out for the first time a direct antioxidant action of this peptide on enterocytes 397 
exposed to oxidizing species. As intestinal concentration of lunasin might be much higher 398 
than serum concentration, these data have an interesting biological significance, suggesting 399 
the possibility that this peptide may significantly contribute to preserve the integrity of 400 
intestinal mucosa against oxidative damage related disorders. Moreover, these results open 401 
the door to future studies on the antioxidant activity of lunasin in other cell lines that 402 
contribute to its already demonstrated properties as chemopreventive and cardioprotective 403 
agent.  404 
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Figure captions 416 
Figure 1. In vitro antioxidant capacity of lunasin measured by ORAC assay: Linear 417 
regression of the net area under the curve (net AUC) vs concentration of (a) Trolox, (b) 418 
Lunasin in the assay. Results are expressed as means of three independent runs. 419 
 420 
Figure 2. Stability of peptide lunasin in DMEM medium added to Caco-2 cells. (a) UV-421 
chromatogram obtained after 16 h-incubation of Caco-2 cells without and with lunasin at 2.5 422 
M. (b) Relative amount of lunasin at different incubation hours (0, 6, 16, and 24 h). 423 
Different superscript letters (a, b) denote statistically significant differences (p<0.05). 424 
 425 
Figure 3. Protective effects of lunasin on cell viability. Caco-2 cells were pre-incubated with 426 
lunasin (concentration ranged from 0.5 to 25 M) for 24 h before treatment with medium 427 
(control cells) or medium supplemented with chemicals (a) hydrogen peroxide (H2O2, 4 mM) 428 
and (b) tert-butyl hydroperoxide (t-BOOH, 3 mM) for 1.5 h, and cell viability was measured 429 
by the MTT assay. Different superscript letters (a-c) denote statistically significant differences 430 
(p<0.05). 431 
 432 
Figure 4. Direct and protective effects of lunasin against intracellular ROS generation. Caco-433 
2 cells were pre-incubated with lunasin (concentration ranged from 0.5 to 25 M) for 24 h 434 
before treatment with medium (control cells) or medium supplemented with hydrogen 435 
peroxide (H2O2, 4 mM) and tert-butyl hydroperoxide (t-BOOH, 3 mM) for 1.5 h, and the 436 
intracellular ROS levels were measured using DCFH as fluorescent probe. Different 437 
superscript letters (a-c) denote statistically significant differences (p<0.05). 438 
 439 
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Figure 5. Direct and protective effects of lunasin against intracellular ROS generation. Caco-440 
2 cells were pre-incubated with lunasin (concentration ranged from 0.5 to 25 M) for 24 h 441 
before treatment with medium (untreated cells) or medium supplemented with hydrogen 442 
peroxide (H2O2, 4 mM) and tert-butyl hydroperoxide (t-BOOH, 3 mM) for 1.5 h, and the 443 
intracellular ROS levels were measured using DHR as fluorescent probe. Different superscript 444 
letters (a-c) denote statistically significant differences (p<0.05). 445 
446 
21 
 
References 447 
- Alía, M., Ramos, S., Mateos, R., Bravo, L., Goya, L., 2005. Response of the antioxidant 448 
defense system to tert-Butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell 449 
line (HepG2). J. Biochem. Mol. Toxicol. 19, 119-128. 450 
- Cam, A., Sivaguru, M., González de Mejia, E., 2013. Endocytic mechanism of 451 
internalization of dietary Peptide lunasin into macrophages in inflammatory condition 452 
associated with cardiovascular disease. PLoS One 8, e72115. 453 
- Carocho, M., Ferreira, I. C. F. R., 2013. A review on antioxidants, prooxidants and related 454 
controversy: Natural and synthetic compounds, screening and analysis methodologies and 455 
future perspectives. Food Chem. Toxicol. 51, 15-25. 456 
- Cilla, A., Laparra, J. M., Alegría, A., Barberá, R., Farré, R., 2008. Antioxidant effect derived 457 
from bioaccessible fractions of fruit beverages against H2O2-induced oxidative stress in Caco-458 
2 cells. Food Chem. 106, 1180-1187. 459 
- Circu, M. L., Aw, T. Y., 2010. Reactive oxygen species, cellular redox systems, and 460 
apoptosis. Free Rad. Biol. Med. 48, 749-762. 461 
- Couto M. R., Gonçalves, P., Catarino, T., Araújo, J. R., Correia-Branco, A., Martel, F., 462 
2012. The effect of oxidative stress upon the intestinal uptake of folic acid: in vitro studies 463 
with Caco-2 cells. Cell Biol. Toxicol. 28, 369-381. 464 
- Dávalos, A., Gómez-Cordovés, C., Bartolomé, B., 2004. Extending applicability of the 465 
oxygen radical absorbance capacity (ORAC Fluorescein) assay. J. Agric. Food Chem.52, 48-466 
54. 467 
- Decker, E. A., Welch, B., 1990. Role of ferritin as a lipid oxidation catalyst in muscle food. 468 
J. Agric. Food Chem. 38, 674-677. 469 
22 
 
- FDA Talk Paper. FDA approves new health claim for soy protein and coronary heart 470 
disease. FDA, United States Department of Health and Human Services, October 26, 1999. 471 
Washington, DC: United States Government Printing Office, 1999. 472 
- Gálvez, A. F., 2012. Abstract 10693: Identification of lunasin as the active component in soy 473 
protein responsible for reducing LDL cholesterol and risk of cardiovascular disease. 474 
Circulation 126, A10693. 475 
- Galvez, A. F., Chen, N., Macasieb, J., de Lumen, B. O., 2001. Chemopreventive property of 476 
a soybean peptide (Lunasin) that binds to deacetylated histones and inhibit acetylation. 477 
Cancer Res. 61, 7473-7478. 478 
- Gálvez, A. F., de Lumen, B. O., 1999. A soybean cDNA encoding a chromatin binding 479 
peptide inhibits mitosis of mammalian cells. Nat. Biotechnol. 17, 495-500. 480 
- Galvez, A. F., Liping, H., Magbanua, M. M. J., Dawson, K., Rodriguez, R. L., 2011. 481 
Differential expression of thrombosponding (THBS1) in tumorigenic and nontumorigenic 482 
prostate epithelial cells in response to a chromatin-binding soy peptide. Nutr. Cancer 63, 623-483 
636. 484 
- García-Nebot, M. J., Cilla, A., Alegría, A., Barberá R., 2011. Caseinophosphopeptides exert 485 
partial and site-specific cytoprotection against H2O2-induced oxidative stress in Caco-2 cells. 486 
Food Chem. 129, 1495-1503.  487 
- Gomes, A., Fernandes, E., Lima, J. L. F. C., (2005). Fluorescence probes used for detection 488 
of reactive oxygen species. J. Biochem. Biophys. Methods 65, 45-80. 489 
- Graham Espey, M., 2013. Role of oxygen gradients in shaping redox relationships between 490 
the human intestine and its microbiota. Free Rad. Biol. Med. 55, 130-140. 491 
- Halliwell, B., Whiteman, M., 2004. Measuring reactive species and oxidative damage in 492 
vivo and in cell culture: how should you do it and what do the results mean? Brit. J. 493 
Pharmacol. 142, 231-255. 494 
23 
 
- Hernández-Ledesma, B., Amigo, L., Recio, I., Bartolome, B., 2007. ACE-inhibitory and 495 
radical-scavenging activity of peptides derived from beta-lactoglobulin f(19-25). Interactions 496 
with ascorbic acid. J. Agric. Food Chem. 55, 3392-3397. 497 
- Hernández-Ledesma, B., Dávalos, A., Bartolomé, B., Amigo, L., 2005. Preparation of 498 
antioxidant enzymatic hydrolyzates from -lactalbumin and -lactoglobulin. Identification of 499 
active peptides by HPLC-MS/MS. J. Agric. Food Chem. 53, 588-593. 500 
- Hernández-Ledesma, B., Hsieh, C. –C., de Lumen, B. O., 2009a. Lunasin, a novel seed 501 
peptide for cancer prevention. Peptides 30, 426-430. 502 
- Hernández-Ledesma, B., Hsieh, C. –C., de Lumen, B. O., 2009b. Lunasin and Bowman-Birk 503 
protease inhibitor (BBI) in US commercial soy foods. Food Chem. 115, 574-580. 504 
- Hernández-Ledesma, B., Hsieh, C. –C., de Lumen, B. O., 2009c. Antioxidant and anti-505 
inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. 506 
Biochem. Biophys. Res. Commun. 390, 803-808. 507 
- Hernández-Ledesma, B., Hsieh, C. –C., de Lumen, B. O., 2013. Chemopreventive properties 508 
of peptide lunasin: a review. Protein Pept. Lett. 20, 424-432. 509 
- Hsieh, C.-C.; Hernández-Ledesma, B.; Jeong, H. J., Park, J. H., Lumen, B. O., 2010. 510 
Complementary roles in cancer prevention: Protease inhibitor makes the cancer preventive 511 
peptide lunasin bioavailable. PLoS ONE 5, e8890. 512 
- Huang, W. –Y., Majumder, K., Wu, J., 2010. Oxygen radical absorbance capacity of 513 
peptides from egg white protein ovotransferrin and their interaction with phytochemicals. 514 
Food Chem. 123, 635-641. 515 
- Jeong, J. B., de Lumen, B. O., Jeong, H. J., 2010. Lunasin peptide purified from Solanum 516 
nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl 517 
radical via blocking fenton reaction. Cancer Lett. 293, 58-64.  518 
24 
 
- Kim, H. J., Lee, E. K., Parke, M. H., Ha, Y. M., Juang, K. J., Kim, M. –S., Kim, M. K., Yu, 519 
B. P., Chung, H. Y., 2013. Ferulate protects the epithelial barrier by maintaining tight junction 520 
protein expression and preventing apoptosis in tert-butyl hydroperoxide-induced Caco-2 cells. 521 
Phytother. Res. 27, 362-367. 522 
- Kitts, D., Weiler, K., 2003. Bioactive proteins and peptides from food sources. Applications 523 
of bioprocesses used in isolation and recovery. Curr. Pharm. Design 9, 1309-1323. 524 
- Lam, Y., Galvez, A., de Lumen, B. O., 2003. Lunasin (TM) suppresses E1A-mediated 525 
transformation of mammalian cells but does not inhibit growth of immortalized and 526 
established cancer cell lines. Nutr. Cancer 47, 88-94. 527 
- Laparra, J. M., Alegría, A., Barberá, R., Farré, R., 2008. Antioxidant effect of casein 528 
phosphopeptides compared with fruit beverages supplemented with skimmed milk against 529 
H2O2-induced oxidative stress in Caco-2 cells. Food Res. Int. 41, 773-779. 530 
- LeBel, C. P., Ishiropoulos, H., Bondy, S. C., 1992. Evaluation of the probe 2’,7’-531 
dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. 532 
Chem. Res. Toxicol. 5, 227-231. 533 
- Li, Y. –W., Li, B., 2013. Characterization of structure–antioxidant activity relationship of 534 
peptides in free radical systems using QSAR models: Key sequence positions and their amino 535 
acid properties. J. Theor. Biol. 318, 29-43. 536 
- Li, J., Liu, Y., Fan, L., Ai, L., Shan, L., 2011. Antioxidant activities of polysaccharides from 537 
the fruiting bodies of Zizyphus Jujuba cv. Jinsixiaozao. Carbohydr. Polym. 84, 390-394. 538 
- Manna, C., Migliardi, V., Sannino, F., De Martino, A., Capasso, R., 2005. Protective effects 539 
of synthetic hydroxytyrosol acetyl derivatives against oxidative stress in human cells. J. 540 
Agric. Food Chem. 53, 9602-9607. 541 
- Martindale, J. L., Holbrook, N. J., 2002. Cellular response to oxidative stress: Signaling for 542 
suicide and survival. J. Cell Physiol. 192, 1-15. 543 
25 
 
- Meisel, H., 2004. Multifunctional peptides encrypted in milk proteins. BioFactors 21, 55-61. 544 
- Owuor, E. D., Kong, A. N. T., 2002. Antioxidants and oxidants regulated signal transduction 545 
pathways. Biochem. Pharmacol. 64, 1547. 546 
- Pavlick, K. P., Laroux, F. S., Fuseler, J., Wolf, R. E., Gray, L., Hoffman, J., Grisham, M. B., 547 
2002. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. 548 
Free Rad. Biol. Med. 33, 311-322. 549 
- Pietta, P., 2000. Flavonoids as antioxidants. J. Nat. Prod. 63, 1035-1042. 550 
- Power, O., Jakeman P., FitzGerald, R. J., 2013. Antioxidative peptides: enzymatic 551 
production, in vitro and in vivo antioxidant activity and potential applications of milk-derived 552 
antioxidative peptides. Amino Acids 44, 797-820. 553 
- Rezaie, A., Parker, R. D., Abdollahi, M., 2007. Oxidative stress and pathogenesis of 554 
inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 52, 2015-2021. 555 
- Royall, J. A., Ischiropoulos, H., 1993. Evaluation of 2’,7’-dichlorofluorescin and 556 
dihydrorhodamine 123 as fluo- rescent probes for intracellular H2O2 in cultured endothelial 557 
cells. Arch. Biochem. Biophys. 302, 348-355. 558 
- Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M. L., Stammati, A., Zucco, F., 2005. The 559 
Caco-2 cell line as a model of the intestinal barrier: influence of cells and culture-related 560 
factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 21, 1-26. 561 
- Silveira, S. T., Martínez-Maqueda, D., Recio, I., Hernández-Ledesma, B., 2013. Dipeptidyl 562 
peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate 563 
rich in -lactoglobulin. Food Chem. 141, 1072-1077. 564 
- Udilova, N., Jurek, D., Marian, B., Gille, L., Schulte-Hermann, R., Nohl, H., 2003. 565 
Induction of lipid peroxidation in biomembranes by dietary oil components. Food Chem. 566 
Toxicol. 41, 1481-1489. 567 
26 
 
- Wang, H., Joseph, J. A., 1999. Quantifying cellular oxidative stress by dichlorofluorescein 568 
assay using microplate reader. Free Radic. Biol. Med. 27, 612-616. 569 
- Wijeratne, S. S. K., Cuppett, S. L., 2007. Oxidative stress induced by lipid hydroperoxides 570 
in the intestine - A review. Agro Food Ind. Hi-Tech 18, 27-29. 571 
- Xie, N., Wang, C., Ao, J., Li, B., 2013. Non-gastrointestinal-hydrolysis enhances 572 
bioavailability and antioxidant efficacy of casein as compared with its in vitro gastrointestinal 573 
digest. Food Res. Int. 51, 114-122. 574 
- Yokomizo, A., Moriwaki, M., 2006. Effects of flavonoids on oxidative stress induced by 575 
hydrogen peroxide in human intestinal Caco-2 cells. Biosci. Biotechnol. Biochem. 70, 1317-576 
1324. 577 
- Zhang, Q. –X., Ling, Y. –F., Sun, Z., Zhang, L., Yu, H. –X., Mburu Kamau, S., Lu, R. –R., 578 
2012. Protective effect of whey protein hydrolysates against hydrogen peroxide-induced 579 
oxidative stress on PC12 cells. Biotechnol. Lett. 34, 2001-2006. 580 
 581 
